NapiFeryn BioTech is a patent holder on a technology of producing protein isolates from oil plant seed, particularly from rapeseed.
NapiFeryn BioTech has raised $2.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.
NapiFeryn BioTech's investors include NutriLeads, Innovopro, EIT Food, EISMEA, ICOS Capital Management.
NapiFeryn BioTech is headquartered in Lodz, Poland.
NapiFeryn BioTech is a patent holder on a technology of producing protein isolates from oil plant seed, particularly from rapeseed.
NapiFeryn BioTech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NapiFeryn BioTech — Funding & Investors." VCBacked, January 30, 2023, https://www.vcbacked.co/company/napiferyn-biotech. Accessed August 14, 2026.
VCBacked. (2023). NapiFeryn BioTech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/napiferyn-biotech
{{cite web |title=NapiFeryn BioTech — Funding & Investors |url=https://www.vcbacked.co/company/napiferyn-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated